Biotechnology - Pharmaceutical, Management

Filter

Current filters:

PharmaceuticalManagement

Popular Filters

Exec appointments at Biogen Idec and Halozyme; Succession plan for Forest Labs

23-05-2013

US biotech firm Biogen Idec (Nasdaq: BIIB) announced that Spyros Artavanis-Tsakonas, has been named chief…

Biogen IdecBiotechnologyForest LaboratoriesHalozyme TherapeuticsManagementPharmaceutical

US Senate confirms appointment of Marilyn Tavenner as CMS Administrator

16-05-2013

US Health and Human Services (HHS) Secretary Kathleen Sebelius announced that the US Senate has confirmed…

BiotechnologyGenericsHealthcareManagementNorth AmericaPharmaceutical

Affymax slashes workforce following Omontys problems; evaluating options

19-03-2013

US biopharma company Affymax (Nasdaq: AFFY) says that it will reduce its workforce as part of a plan…

AffymaxBiotechnologyFinancialManagementOmontysOncologyPharmaceutical

Roche granted EU approval for Perjeta; board appointments

06-03-2013

The European Medicines Agency has approved Swiss drug major Roche's (ROG: SIX) Perjeta (pertuzumab) for…

BiotechnologyEuropeManagementOncologyPerjetaPharmaceuticalRegulationRoche

New US Federal Trade Commission chairman - Edith Ramirez - to be designated by President

03-03-2013

President Barack Obama intends to designate Edith Ramirez as Chairman of the Federal Trade Commission…

BiotechnologyGenericsManagementNorth AmericaPharmaceuticalRegulation

Biopharma facing hiring difficulties and R&D talent gap, PwC unit finds

04-02-2013

A talent gap in the scientific workforce has biopharmaceutical companies searching outside for fresh…

BiotechnologyManagementNorth AmericaPharmaceuticalResearch

Drugmakers spend an average $237,000 per medical science liaison in the USA

31-10-2012

US-based drug companies spend an average $237,000 on each of their medical science liaisons (MSLs), but…

BiotechnologyGlobalManagementMarkets & MarketingPharmaceutical

The way forward in health care, by Gilbert Mertens

28-10-2012

Preparing for a future of unseen opportunity in health care requires a profound shift in thinking from…

BiotechnologyHealthcareManagementPharmaceuticalResearch

Patient adherence efforts gain more recognition throughout US pharma industry

14-10-2012

Since 2009, US pharmaceutical companies have increased their patient adherence budgets by 281%, according…

BiotechnologyManagementMarkets & MarketingNorth AmericaPharmaceutical

Sanofi to cut 900 French research posts, a lot fewer than had been feared

25-09-2012

French drug major Sanofi (Euronext: SAN) yesterday fleshed out on its plans for changes in its research…

BiotechnologyEuropeManagementPharmaceuticalResearchSanofi

Addressing the boardroom gender gap in life sciences industry

23-09-2012

Nick Stephens, executive chairman of RSA, a global life sciences executive search and interim management…

BiotechnologyEuropeManagementPharmaceutical

Merck Serono creates second company under EPP

03-09-2012

Merck Serono, a division of Germany's Merck KGaA (MRK: DE), has established Quartz Bio, the second spin-off…

BiotechnologyManagementMerck KGaAMerck SeronoPharmaceuticalQuartz Bio

Pharmaceutical sales rep access reducing most among oncologists in USA

28-08-2012

As more pharmaceutical companies prepare to bring new oncology drugs to market, their sales representatives…

BiotechnologyManagementMarkets & MarketingNorth AmericaOncologyPharmaceutical

Dainippon Sumitomo to set up DSP Cancer Institute

21-08-2012

Japanese drug major Dainippon Sumitomo Pharma (TYO: 4506) says it plans to establish a new organization…

BiotechnologyDainippon Sumitomo PharmaManagementOncologyPharmaceuticalResearch

Merck Serono sets up Prexton Therapeutics as first spin-off from its Entrepreneur Partnership Program

31-07-2012

Merck Serono, a division of Germany's Merck KGaA (MRK: DE), has created Prexton Therapeutics, the first…

BiotechnologyLicensingManagementMerck KGaAMerck SeronoNeurologicalPharmaceuticalPrexton TherapeuticsResearch

New business model to relaunch the BioPharma industry, from ADL

01-05-2012

Traditionally, clinical diagnoses and treatments have focused on diseases and cures. For every ailment,…

BiotechnologyManagementMarkets & MarketingPharmaceutical

Merck KGaA to rationalize operations in Switzerland

24-04-2012

German drug major Merck KGaA (MRK: DE) has announced efficiency measures it plans to take related to…

BiotechnologyManagementMerck KGaAMerck SeronoPharmaceuticalResearch

Musical chairs at Amgen and Roche

19-12-2011

USA-based Amgen (Nasdaq: AMGN), the world’s largest independent biotech company, says that Kevin…

AmgenBiotechnologyManagementPharmaceuticalRoche

Parexel

Parexel

Back to top